Inovio Pharmaceuticals Stock up 16.36% as HPV drug shows promise
Inovio Pharmaceuticals stock soared by +16.36% on Friday, as HPV drug VGX-3100 showed promise in Phase 2 Trial. Shares of
Read more
Oncology
Gilead to acquire immuno-oncology company Forty Seven for $4.9 Billion
Gilead to acquire clinical-stage immuno-oncology company Forty Seven for $4.9 Billion Gilead Sciences, Inc. and Forty Seven, Inc. announced that
Read more
Paris-Saclay Research Institute, Servier Group
The Servier Group has commenced the construction of its ultra-modern Research Institute in the Paris-Saclay cluster in France. Covering approximately 45,000 m2,
Read more
Skin cancer drug trial boosts CK Life Sciences stock by 240%
CK Life Sciences stock jumps 240% as skin cancer drug trial looks promising. Seviprotimut-L could serve as a significant innovation in the vaccine-based treatment of melanoma.
Read more